Microalbuminuria and Allopurinol in Type 1 Diabetes
Status:
Completed
Trial end date:
2017-09-20
Target enrollment:
Participant gender:
Summary
The objective is to determine if lowering serum uric acid by means of allopurinol in the
course of kidney disease may be effective in preventing or improving albuminuria and renal
function in Type 1 Diabetic patients. The study is a double blinded, randomised,
placebo-controlled cross-over clinical trial.